These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27737475)

  • 1. Pharmacotherapy in Children and Adolescents at Clinical-High Risk for Psychosis and Bipolar Disorder.
    Lambert M; Niehaus V; Correll C
    Pharmacopsychiatry; 2016 Nov; 49(6):229-244. PubMed ID: 27737475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: a review of the randomized controlled studies.
    Zuddas A; Zanni R; Usala T
    Eur Neuropsychopharmacol; 2011 Aug; 21(8):600-20. PubMed ID: 21550212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: comprehensive review of prospective head-to-head and placebo-controlled comparisons.
    Fraguas D; Correll CU; Merchán-Naranjo J; Rapado-Castro M; Parellada M; Moreno C; Arango C
    Eur Neuropsychopharmacol; 2011 Aug; 21(8):621-45. PubMed ID: 20702068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Misdiagnosis, duration of untreated illness (DUI) and outcome in bipolar patients with psychotic symptoms: A naturalistic study.
    Altamura AC; Buoli M; Caldiroli A; Caron L; Cumerlato Melter C; Dobrea C; Cigliobianco M; Zanelli Quarantini F
    J Affect Disord; 2015 Aug; 182():70-5. PubMed ID: 25978716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
    Munch G; Godart N
    Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interventions for youth at high risk for bipolar disorder and schizophrenia.
    McNamara RK; Strawn JR; Chang KD; DelBello MP
    Child Adolesc Psychiatr Clin N Am; 2012 Oct; 21(4):739-51. PubMed ID: 23040899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychopharmacology of Bipolar Disorders in Children and Adolescents.
    Stepanova E; Findling RL
    Pediatr Clin North Am; 2017 Dec; 64(6):1209-1222. PubMed ID: 29173781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic interventions in prodromal psychosis: safety issues.
    Liu CC; Demjaha A
    CNS Drugs; 2013 Mar; 27(3):197-205. PubMed ID: 23436256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment options for children and adolescents with bipolar disorder.
    Findling RL
    J Clin Psychiatry; 2009 Sep; 70(9):e34. PubMed ID: 19818240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concerns.
    Vitiello B; Correll C; van Zwieten-Boot B; Zuddas A; Parellada M; Arango C
    Eur Neuropsychopharmacol; 2009 Sep; 19(9):629-35. PubMed ID: 19467582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescribing of antipsychotics in UK primary care: a cohort study.
    Marston L; Nazareth I; Petersen I; Walters K; Osborn DP
    BMJ Open; 2014 Dec; 4(12):e006135. PubMed ID: 25524544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward convergence in the medication treatment of bipolar disorder and schizophrenia.
    Citrome L; Goldberg JF; Stahl SM
    Harv Rev Psychiatry; 2005; 13(1):28-42. PubMed ID: 15804932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacological treatment of bipolar disorder in children and adolescents].
    Bailly D
    Encephale; 2017 May; 43(3):254-258. PubMed ID: 27198073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-Based Pharmacologic Treatment of Pediatric Bipolar Disorder.
    Findling RL
    J Clin Psychiatry; 2016; 77 Suppl E1():e2. PubMed ID: 27570928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential use of lurasidone for the treatment of bipolar psychosis.
    Carta MG; Moro MF; Nardi AE; Calabrese JR
    Expert Opin Investig Drugs; 2015 Apr; 24(4):575-84. PubMed ID: 25633339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Retrospective Investigation of Clozapine Treatment in Autistic and Nonautistic Children and Adolescents in an Inpatient Clinic in Turkey.
    Yalcin O; Kaymak G; Erdogan A; Tanidir C; Karacetin G; Kilicoglu AG; Mutlu C; Adaletli H; Gunes H; Bahali K; Ayik B; Uneri OS
    J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):815-821. PubMed ID: 26771824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aripiprazole in pediatric psychosis and bipolar disorder: a clinical review.
    Doey T
    J Affect Disord; 2012; 138 Suppl():S15-21. PubMed ID: 22406333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.